The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate

Platelets

Volumn 17, Issue 7, 2006, Pages 441-447

  Akarasereenont, Pravit ^a,b   Tripatara, Pinpat ^a   Chotewuttakorn, Sirikul ^a   Palo, Titchaporn ^a   Thaworn, Athiwat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Estradiol; Estriol; Estrone; Hormone; Platelet aggregation; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; CITRIC ACID; ESTRADIOL; ESTRIOL; ESTRONE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BLOOD DONOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MICROTITER PLATE ASSAY; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ADULT; AGED; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; ESTRADIOL; ESTRADIOL CONGENERS; ESTRIOL; ESTRONE; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; PLATELET AGGREGATION;

EID: 33750503604     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100600745302     Document Type: Article

References (29)

1. Wolf PH, Madans JH, Finucane FF, Higgins M, Kleinman JC. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: Evidence from a national cohort. Am J Obstet Gynecol 1991;164:489-494.
2. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. New Engl J Med 1985;313:1044-1049.
3. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. J Am Med Assoc 1995;273:199-208.
4. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-1687.
5. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993;109:612-617.
6. Williams JK, Anthony MS, Honore EK, Herrington DM, Morgan TM, Register TC, Clarkson TB. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol 1995;15:827-836.
7. Levi M, Middeldorp S, Buller HR. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism. Cardiovasc Res 1999;41:21-24.
8. Poller L. Oral contraceptives, blood clotting and thrombosis. Br Med Bull 1978;34:151-156.
9. Teede HJ, McGrath BP, Smolich JJ, Malan E, Kotsopoulos D, Liang YL, Peverill RE. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol 2000;20:1404-1409.
10. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605-613.
11. Anderson TJ. Nitric Oxide, Atherosclerosis and the Clinical Relevance of Endothelial Dysfunction. Heart Failure Rev 2003;8:71-86.
12. Elkeles RS, Hampton JR, Mitchell JR. Effect of oestrogens on human platelet behaviour. Lancet 1968;ii:315-318.
13. Poller L. Oral contraception and platelet aggregation. Acta Med Scand Suppl 1971;525:197-201.
14. Altman R, Taboada S, Zielinsky A. The effect in vitro of the steroidal component of oral contraceptives on platelet aggregation. Experientia 1974;30:1203.
15. Toy JL, Davies JA, Hancock KW, McNicol GP. The effects of an increase in endogenous oestrogen on the haemostatic mechanism. Thromb Haemost 1978;39:683-688.
16. Ishak R, Mohamed AB, Hassan K. Platelet function studies in women on oral contraceptive pills. Malays J Reprod Health 1990;8:1-4.
17. Bar J, Tepper R, Fuchs J, Pardo Y, Goldberger S, Ovadia J. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol 1993;81:261-264.
18. Nakano Y, Oshima T, Matsuura H, Kajiyama G, Kambe M. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Arterioscler Thromb Vasc Biol 1998;18:961-967.
19. Nakano Y, Oshima T, Ozono R, Ueda A, Oue Y, Matsuura H, Sanada M, Ohama K, Chayama K, Kambe M. Estrogen replacement suppresses function of thrombin stimulated platelets by inhibiting Ca(2+) influx and raising cyclic adenosine monophosphate. Cardiovasc Res 2002;53:634-641.
20. Seelig MS, Altura BM, Altura BT. Benefits and risks of sex hormone replacement in postmenopausal women. J Am Coll Nutr 2004;23:482S-496S.
21. Khetawat G, Faraday N, Nealen ML, Vijayan KV, Bolton E, Noga SJ, Bray PF. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): Testosterone regulates AR expression. Blood 2000;95:2289-2296.
22. Jayachandran M, Miller VM. Human platelets contain estrogen receptor α, caveolin-1 and estrogen receptor associated proteins. Platelet 2003;14:75-81.
23. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and Actions of Estrogens. New Engl J Med 2002;346:340-352.
24. Nealen ML, Vijayan KV, Bolton E, Bray PF. Human platelets contain a glycosylated estrogen receptor beta. Circ Res 2001;88:438-442.
25. Littleton-Kearney MT, Gaines JM, Callahan KP, Murphy SJ, Hurn PD. Effects of estrogen on platelet reactivity after transient forebrain ischemia in rats. Biol Res Nurs 2005;7:135-145.
26. Krause S, Scholz T, Temmler U, Losche W. Monitoring the effects of platelet glycoprotein IIb/IIIa antagonists with a microtiter plate method for detection of platelet aggregation. Platelets 2001;12:423-430.
27. Akarasereenont P, Aiamsa-ard T, Chotewuttakorn S, Thaworn A. The activation of platelet aggregation by human Cholangiocarcinoma cells is mediated through thrombin receptor. J Med Assoc Thai 2001;84(Suppl 3):S710-721.
28. Jayachandran M, Mukherjee R, Steinkamp T, LaBreche P, Bracamonte MP, Okano H, Owen WG, Miller VM. Differential effects of 17{beta}-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets. Am J Physiol Heart Circ Physiol 2005;288:H2355-H2362.
29. Jayachandran M, Miller VM. Ovarectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets. Am J Physiol Heart Circ Physiol 2002;283:H220-H226.